Sequential induction of pro- and anti-inflammatory prostaglandins and peroxisome proliferators-activated receptor-gamma during normal wound healing: A time course study

被引:51
作者
Kapoor, Mohit [1 ]
Kojima, Fumiaki [1 ]
Yang, Lihua [1 ]
Crofford, Leslie J. [1 ]
机构
[1] Univ Kentucky, Kentucky Clin, Div Rheumatol, Dept Internal Med, Lexington, KY 40536 USA
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2007年 / 76卷 / 02期
关键词
D O I
10.1016/j.plefa.2006.11.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid mediators generated from metabolism of arachidonic acid play a crucial role in the initiating and resolution of acute inflammation by shifting from pro-inflammatory prostaglandin (PG) E-2 to anti-inflammatory PGD(2) and its metabolites. The changes in PG levels over time during the normal wound-repair process have not, however, been reported. We determined the temporal expression of PG and their biosynthetic enzymes using the full thickness incisional model of normal wound healing in mice. We demonstrate that during normal wound repair, there is a shift in the metabolism of arachidonate from PGE(2) during the acute inflammatory phase to PGD(2) during the repair phase. This shift is mediated by temporal changes in the expression of cyclooxygenases (COX) and microsomal PGES (mPGES)-1. Inducible COX (COX-2) expression is sustained throughout the initiation and repair process, but mPGES-1 is increased only during the acute inflammatory phase and its disappearance coincides with increased PGD(2). PGD(2) and its degradation products are known to mediate their anti-inflammatory effects by binding to peroxisome proliferators-activated receptor gamma (PPAR gamma). In this study, we show that PPAR gamma is upregulated during the resolution phase of wound repair concomitant with the shift to PGD(2), and may be responsible for initiating endogenous mechanism resulting in healing/resolution. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:103 / 112
页数:10
相关论文
共 45 条
[1]   Retrovirally introduced prostaglandin D2 synthase suppresses lung injury induced by bleomycin [J].
Ando, M ;
Murakami, Y ;
Kojima, F ;
Endo, H ;
Kitasato, H ;
Hashimoto, A ;
Kobayashi, H ;
Majima, M ;
Inoue, M ;
Kondo, H ;
Kawai, S ;
Hayashi, I .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2003, 28 (05) :582-591
[2]   COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression [J].
Chandrasekharan, NV ;
Dai, H ;
Roos, KLT ;
Evanson, NK ;
Tomsik, J ;
Elton, TS ;
Simmons, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) :13926-13931
[3]   Prostaglandin biology [J].
Crofford, LJ .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2001, 30 (04) :863-+
[4]   Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor γ [J].
Cuzzocrea, S ;
Mazzon, E ;
Dugo, L ;
Patel, NSA ;
Serraino, I ;
Di Paola, R ;
Genovese, T ;
Britti, D ;
De Maio, M ;
Caputi, AP ;
Thiemermann, C .
ARTHRITIS AND RHEUMATISM, 2003, 48 (12) :3544-3556
[5]   The cyclopentenone prostaglandin 15-deoxy-Δ12,14-prostaglandin J2 attenuates the development of acute and chronic inflammation [J].
Cuzzocrea, S ;
Wayman, NS ;
Mazzon, E ;
Dugo, L ;
Di Paola, R ;
Serraino, I ;
Britti, D ;
Chatterjee, PK ;
Caputi, AP ;
Thiemermann, C .
MOLECULAR PHARMACOLOGY, 2002, 61 (05) :997-1007
[6]   COX-3: in the wrong frame in mind [J].
Dinchuk, JE ;
Liu, RQ ;
Trzaskos, JM .
IMMUNOLOGY LETTERS, 2003, 86 (01) :121-121
[7]  
Fahmi H, 2001, ARTHRITIS RHEUM, V44, P595, DOI 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.0.CO
[8]  
2-8
[9]   Inhibition of interleukin-1β-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Δ12,14-prostaglandin J2 through a histone deacetylase-independent mechanism [J].
Farrajota, K ;
Cheng, S ;
Martel-Pelletier, J ;
Afif, H ;
Pelletier, JP ;
Li, XF ;
Ranger, P ;
Fahmi, H .
ARTHRITIS AND RHEUMATISM, 2005, 52 (01) :94-104
[10]   BIOLOGICAL-ACTIVITIES AND MECHANISMS OF ACTION OF PGJ2 AND RELATED-COMPOUNDS - AN UPDATE [J].
FUKUSHIMA, M .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1992, 47 (01) :1-12